GEORGETOWN UNIVERSITY HOSPITAL
1. Target Overview & Investment Thesis
GEORGETOWN UNIVERSITY HOSPITAL is a 402-bed suburban community hospital in DC, DC with $1.11B in net patient revenue and a 6.3% operating margin. The hospital serves a payer mix of 30.9% Medicare, 6.8% Medicaid, and 62.3% commercial.
Thesis: Platform Growth. Our ML models identify $81.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 6.3% to 13.7% (+736bps).
| Net Revenue HCRIS | $1.11B |
| Current EBITDA COMPUTED | $69.9M |
| Operating Margin COMPUTED | 6.3% |
| Occupancy HCRIS | 82.9% |
| Revenue / Bed COMPUTED | $2.8M |
| Net-to-Gross HCRIS | 31.7% |
| Distress Probability ML | 40.3% |
2. Market Context & Competitive Position
DC has 12 Medicare-certified hospitals with a median operating margin of -2.9%. The target's margin of 6.3% places it above the state median. Among 1166 size-comparable peers (201-804 beds), the median margin is -3.8%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (201-804), prioritizing same-state peers. 1166 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| GEORGETOWN UNIVERSITY HOSPITAL (Target) | DC | 402 | $1.11B | 6.3% |
| ST. LUKES HOSPITAL | PA | 633 | $8.94B | 87.9% |
| STANFORD HEALTH CARE | CA | 657 | $6.76B | 3.7% |
| UT MD ANDERSON CANCER CENTER | TX | 721 | $4.90B | -0.8% |
| MEMORIAL HOSPITAL FOR CANCER A | NY | 514 | $4.34B | -32.5% |
| STRONG MEMORIAL HOSPITAL | NY | 749 | $3.31B | 5.2% |
| UC DAVIS MEDICAL CENTER | CA | 666 | $3.28B | -11.5% |
| UCSD MEDICAL CENTER | CA | 718 | $3.06B | -7.2% |
| UNIVERSITY OF NORTH CAROLINA H | NC | 799 | $2.88B | 13.3% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $81.6M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $23.3M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $22.2M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $21.9M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $13.5M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $709K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $69.9M |
| + RCM Uplift | +$81.6M |
| Pro Forma EBITDA | $151.4M |
| Current Margin | 6.3% |
| Pro Forma Margin | 13.7% |
| WC Released (1x) | $42.5M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $107.5M | $1.28B | 11.87x | 64.0% |
| Base (11x exit) | 10.0x | 11.0x | $107.5M | $1.44B | 13.39x | 68.0% |
| Bull Case | 9.0x | 11.0x | $96.8M | $1.74B | 18.02x | 78.3% |
| Bull (12x exit) | 9.0x | 12.0x | $96.8M | $1.93B | 19.95x | 82.0% |
| Bear Case | 11.0x | 10.0x | $118.3M | $833.9M | 7.05x | 47.8% |
| Bear (11x exit) | 11.0x | 11.0x | $118.3M | $955.7M | 8.08x | 51.9% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 1166 hospitals with 201-804 beds
- Same-state prioritization (n=7)
- Comp margins: P25=-13.2% / P50=-3.8% / P75=5.0%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.